Epidemiologists forecast an increase in the diagnosed prevalent cases of T2D in the 9MM, from 116,871,808 diagnosed prevalent cases in 2015 to 151,907,657 diagnosed prevalent cases in 2025, with an Annual Growth Rate (AGR) of 3.00%. The projected increase in the diagnosed prevalent cases of T2D across all the markets covered in this analysis is attributed to the actual increase in the incidence of T2D along with the change in population demographics in the respective markets.
Our epidemiologists utilized country-specific diagnosed prevalence data for T2D across the 9MM. Additionally, the epidemiological forecast for the diagnosed prevalent cases of T2D in the 9MM is supported by nationally representative longitudinal historical data obtained from studies in respective countries published in peer-reviewed journals or national healthcare databases, which provide a detailed insight into the epidemiology of the disease in these markets.
- The Type 2 Diabetes (T2D) EpiCast Report provides an overview of the risk factors and global trends of T2D in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, China, and India).
- It includes a 10-year epidemiology forecast of T2D diagnosed prevalent cases segmented by age (in ten-year increments beginning at ages 20-30 years and ending at age 80 years and older), sex, and comorbidities including chronic kidney disease (CKD), cardiovascular disease (CVD), overweight/obesity, hypertension, and dyslipidemia in these nine markets.
- The T2D epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.
Key Topics Covered:
1 Tables & Figures
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global Trends
3.3.4 China and India
3.4 Forecast Methodology
3.4.1 Sources Used for Diagnosed Prevalence of T2D
3.4.2 Sources Not Used
3.4.3 Forecast Assumptions and Methods, Diagnosed Prevalent Cases of T2D
3.5 Epidemiological Forecast for T2D (2015-2025)
3.5.1 Diagnosed Prevalent Cases of T2D
3.5.2 Age-Specific Diagnosed Prevalent Cases of T2D
3.5.3 Sex-Specific Diagnosed Prevalent Cases of T2D
3.5.4 Age-Standardized Diagnosed Prevalence of T2D
3.5.5 Prevalent Cases of Chronic Kidney Disease Among Diagnosed T2D Cases
3.5.6 Prevalent Cases of Cardiovascular Disease Among Diagnosed T2D Cases
3.5.7 Prevalent Cases of Overweight/Obesity Among Diagnosed T2D Cases
3.5.8 Prevalent Cases of Hypertension Among Diagnosed T2D Cases
3.5.9 Prevalent Cases of Dyslipidemia Among Diagnosed T2D Cases
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis
Please find more about Research Report: Type 2 Diabetes - Epidemiology Forecast to 2025 at reports.zursh.com
Click on below items to see free updates about the topic covered.
Click on below items to see free resources and reports about the topic covered.